JAMA ophthalmology

The most recent articles from: JAMA Ophthalmol February 2017

JAMA ophthalmology · Feb 2017

Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical Trials.

Information on the effect of anti-vascular endothelial growth factor therapy in eyes with diabetic macular edema (DME) with vision loss after macular laser photocoagulation is clinically valuable. ⋯ Intravitreal aflibercept injection improves visual and anatomic outcomes in eyes experiencing substantial vision loss after macular laser photocoagulation treatment for DME.

read more… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.